Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Halozyme Therapeutics Inc HALO

Healthcare Biotechnology
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. The Company’s ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, its commercially validated solution is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids, with a focus on... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:HALO)

Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions

PR Newswire 16 hours ago

Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction

PR Newswire 8 days ago

HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS

PR Newswire October 31, 2024

HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE

PR Newswire October 24, 2024

Halozyme to Report Third Quarter 2024 Financial and Operating Results

PR Newswire October 23, 2024

Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE®

PR Newswire October 3, 2024

Kaskela Law LLC Announces Shareholder Investigation of Halozyme Therapeutics, Inc. (HALO) and Encourages Investors to Contact the Firm

Business Wire September 17, 2024

Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO(TM) with ENHANZE® for People with Relapsing and Primary Progressive Multiple Sclerosis

PR Newswire September 13, 2024

Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza(TM) With ENHANZE® for Multiple Types of Cancer

PR Newswire September 12, 2024
View More News ››

Opinion & Analysis (NDAQ:HALO)

Biotechs Struggling To Find A Bottom

Benzinga.com  April 8, 2014
View More Opinion ››

Bullboard Posts (NDAQ:HALO)

Halozyme's ENHANZE Product Gets New Patent Grant in EU | Ben

Just In: $HALO Halozyme's ENHANZE Product Gets New Patent Grant in EU | BenzingaHalozyme Therapeutics@(NASDAQ: HALO) announced that...
whytestocks - June 6, 2024

Positive Topline Data Reported from argenx's ADHERE Study of

Just In: $HALO Positive Topline Data Reported from argenx's ADHERE Study of VYVGART&#xAE; Hytrulo with Halozyme's ENHANZE...
whytestocks - July 17, 2023

(Halo) reported financials for 1st Q.

Must read from : www.thewallstreetvoice.com  https://secure.campaigner.com/CSB/public/archive.aspx?args=NjAwNzI1Ng%3d%3d
snaidenoff - May 13, 2014
View more Bullboard ››

Pinnacle Silver & Gold Corp

Pinnacle Silver & Gold Corp

Pinnacle is currently focused on district-scale exploration for precious metals in the prolific Red Lake District of ...
View More »